Study of Obeldesivir in Children and Adolescents With COVID-19
Status:
Terminated
Trial end date:
2024-02-23
Target enrollment:
Participant gender:
Summary
The goal of this clinical study is to learn more about the safety and tolerability of
obeldesivir (ODV) in children and adolescents with coronavirus disease 2019 (COVID-19).
The primary objectives are to evaluate the plasma pharmacokinetics (PK), safety and
tolerability of ODV in pediatric participants with COVID-19.